(Q46777626)

25 December 2017

title

Effects of antiepileptic drugs on attention as assessed by a five-choice serial reaction time task in rats (English)

1 reference

25 December 2017

1 reference

Harlan E Shannon

1

1 reference

25 December 2017

Patrick L Love

series ordinal

2

1 reference

25 December 2017

publication date

25 October 2005

1 reference

25 December 2017

published in

Epilepsy Behavior

1 reference

25 December 2017

volume

7

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

620-628

1 reference

25 December 2017

Current discoveries on the cognitive effects of antiepileptic drugs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Neuropsychological effects of epilepsy and antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Cognitive functioning in community dwelling older adults with chronic partial epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Comparative cognitive effects of anticonvulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Differential cognitive effects of carbamazepine and gabapentin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Attentional Ability in Children with Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Effects of biasing the location of stimulus presentation, and the muscarinic cholinergic receptor antagonist scopolamine, on performance of a 5-choice serial reaction time attention task in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Comparative cognitive effects of carbamazepine and phenytoin in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Effects of carbamazepine and phenytoin on EEG and memory in healthy adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Sodium valproate and cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

A summary of mechanistic hypotheses of gabapentin pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Differential cognitive and behavioral effects of carbamazepine and lamotrigine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

An audit of topiramate use in a general neurology clinic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Factors associated with behavioral and cognitive abnormalities in children receiving topiramate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

The effects of adjunctive topiramate on cognitive function in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.08.017

10.1016/J.YEBEH.2005.08.017

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16253568

1 reference

25 December 2017